有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
Premium Digital
。51吃瓜对此有专业解读
18:22, 27 февраля 2026Ценности
Then Firefox has some good news for you. The popular web browser, which is run by the non-profit-owned tech company Mozilla, has just rolled out a new update that comes with an AI killswitch.
item.get("title"),